Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001808805-24-000060
Filing Date
2024-09-17
Accepted
2024-09-17 16:40:38
Documents
3
Period of Report
2024-09-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1726605630.html 3  
1 FORM 3 wk-form3_1726605630.xml 3 1707
2 EX-24 nautilusbiotechnology-se.htm EX-24 2662
3 nautilusbiotechnology-se001.jpg GRAPHIC 178459
  Complete submission text file 0001808805-24-000060.txt   251785
Mailing Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address 2701 EASTLAKE AVE EAST SEATTLE WA 98102 206-333-2001
Nautilus Biotechnology, Inc. (Issuer) CIK: 0001808805 (see all company filings)

EIN.: 981541723 | Fiscal Year End: 1231
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)

Mailing Address C/O NAUTILUS BIOTECHNOLOGY 2701 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address
Suzuki Kentaro (Reporting) CIK: 0002037191 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39434 | Film No.: 241304962